Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MindLinc is a behavioral health electronic health record and practice management platform originally developed at Duke University School of Medicine and later acquired by Holmusk. The product focuses on specialty psychiatry and behavioral health workflows, including clinical documentation, decision support, billing, regulatory management, and outcomes tracking. MindLinc also underpins a longitudinal psychiatric clinical data repository that has been used for research, benchmarking, and real-world evidence generation. Following its acquisition, MindLinc has functioned as part of Holmusk's broader behavioral health data and analytics strategy rather than as a standalone drug-development company. The business is healthcare IT and data infrastructure, not a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MindLinc.